Nanobiotix S.A.
Nanobiotix develops JNJ-1900, a hafnium oxide nanoparticle injected into tumors and activated by radiotherapy to trigger tumor cell death and immune response.
6-KSep 24Latest SEC filing, period to Jun 30
Sep 24Latest story
September 2026